Highlights
NASDAQ: SRRA       Sierra Oncology Inc
Last Price Today's Change   Day's Range   Trading Volume
14.49   +0.66 (4.77%)  13.77 - 15.79  33,100

Overview

 
Avg Volume (4 weeks):20,663
4 Weeks Range:11.10 - 15.79
4 Weeks Price Volatility (%):
72.28%
52 Weeks Range:0.216 - 16.89
52 Weeks Price Volatility (%):
85.61%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1 clinical trial to treat patients with advanced cancer. In addition, it also engaged in developing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase that is in the preclinical development stage.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5469  2756  473  149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GNUS 7.93+3.91 
 NIO 5.60+0.90 
 GE 7.36+0.31 
 VISL 0.425+0.086 
 F 6.19+0.29 
 SPY 312.18+4.10 
 BAC 25.99+1.15 
 AAL 11.85+0.63 
 UAL 33.65+3.74 
 SAVA 3.42+1.38 
Partners & Brokers